Deep brain stimulation and focused ultrasound are medical technologies used to treat certain neurological conditions, including movement disorders. Although both approaches target specific areas of the brain, they work in different ways. Deep brain stimulation involves implanting electrodes that deliver controlled electrical signals, while focused ultrasound uses concentrated sound waves to affect selected brain tissue.
Deep brain stimulation (DBS) and focused ultrasound are specialized procedures used in selected patients when symptoms are not adequately controlled with medication or when particular treatment goals require another approach. DBS has been used for conditions such as Parkinson's disease, essential tremor, and dystonia. Focused ultrasound is also used for certain movement disorders, with its applications depending on the specific procedure, condition, and regulatory approval. Neither treatment is suitable for everyone, and a specialist assessment is essential before considering either option.
Deep brain stimulation involves placing thin electrodes in targeted brain regions through a surgical procedure. The electrodes connect to a pulse generator, typically implanted under the skin near the chest. The device delivers electrical impulses that influence abnormal neural activity associated with certain symptoms. Clinicians can adjust stimulation settings over time to help manage symptoms and balance treatment effects.
Focused ultrasound uses concentrated sound waves to create a targeted effect within selected brain tissue. Some procedures create a small, permanent lesion, while other ultrasound approaches use different techniques and purposes. Magnetic resonance imaging is commonly used to guide and monitor magnetic resonance guided focused ultrasound procedures. Unlike DBS, lesion-producing focused ultrasound does not require implanted brain electrodes or a pulse generator.
Important differences include:
Treatment method: DBS uses electrical stimulation, whereas lesion-producing focused ultrasound changes a targeted area of brain tissue using concentrated ultrasound energy.
Surgical approach: DBS requires electrode implantation and placement of a device. Focused ultrasound procedures generally avoid an incision in the skull, although the specific preparation and technique vary.
Adjustability: DBS settings can be modified after implantation. A lesion created by focused ultrasound is generally irreversible.
Follow-up care: DBS usually requires device programming, battery monitoring, and ongoing clinical appointments. Focused ultrasound follow-up focuses on symptom response, adverse effects, and continued neurological assessment.
Treatment suitability: The best option depends on the condition, symptoms, imaging findings, general health, and the patient's treatment preferences.
Both approaches may reduce specific symptoms in appropriately selected patients, but neither guarantees improvement or stops every aspect of a neurological disease. Their effectiveness varies according to the condition being treated, the targeted brain region, and individual clinical factors.
DBS may offer an important advantage for people who need adjustable symptom management. However, implantation involves surgical risks, including bleeding, infection, and complications related to the implanted hardware. Stimulation can also cause effects such as speech changes, balance difficulties, or involuntary movements, depending on the treatment settings and brain region.
Focused ultrasound avoids implanted hardware and generally does not require an incision in the skull. Nevertheless, it can cause side effects, including headache, dizziness, sensory changes, or balance and gait problems. Some neurological effects may persist, and the tissue changes produced by lesion-forming procedures cannot simply be reversed.
Other considerations include:
Recovery: Recovery varies with the procedure and individual health. DBS involves surgical recovery and subsequent programming visits, while focused ultrasound patients require monitoring for immediate and delayed adverse effects.
Long-term management: DBS may require adjustments over time as symptoms or treatment needs change. Focused ultrasound outcomes depend on the durability of the treatment effect and the condition being managed.
Medical eligibility: Brain imaging, neurological evaluation, medication response, and other health factors help determine whether a patient qualifies for either procedure.
Treatment goals: Specialists consider symptom reduction, daily functioning, possible adverse effects, and personal preferences when comparing options.
Deep brain stimulation and focused ultrasound serve different clinical needs, and the choice should be based on individualized medical assessment rather than a general assumption that one method is better. Patients can discuss expected outcomes, uncertainties, possible complications, alternatives, and follow-up requirements with a movement disorder neurologist or functional neurosurgeon. Understanding how each procedure works provides a foundation for informed discussions about neurological care.